Form 4: ClearPoint Neuro Director Linda M. Liau Reports Acquisition of Restricted Stock Units

Director Linda M. Liau reports acquisition of 21,093 restricted stock units in ClearPoint Neuro, Inc.

Summary

• On May 16, 2024, Linda M. Liau, a director of ClearPoint Neuro, Inc. (CLPT), acquired 21,093 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of CLPT common stock.
• The RSUs vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders.
• Following the transaction, Liau directly owns 21,093 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock options, indicating a neutral sentiment.

Future Outlook

The vesting of the restricted stock units will result in the issuance of ClearPoint Neuro common stock to Linda M. Liau, contingent on her continued service.

Industry Context

This filing is a routine disclosure of stock-based compensation to a company director, which is a common practice in publicly traded companies to align the interests of management with those of shareholders.

Stakeholder Impact

• The acquisition of restricted stock units by a director aligns her interests with those of shareholders, potentially incentivizing her to work towards increasing shareholder value.

Key Dates